Psychometric Validation of the EORTC QLQ-PAN26 Pancreatic Cancer Module for Assessing Health Related Quality of Life after Pancreatic Resection

Context The European Organization for Research and Treatment of Cancer has developed the PAN26 instrument to measure quality of life in patients with pancreatic cancer. Its use has been increasing, but it has not yet undergone psychometric validation in a large cohort or in the setting of pancreatic resection. Objective We aimed to validate the PAN26 in patients undergoing pancreatic resection using a highquality Phase III clinical trial...